Stay updated on Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Sign up to get notified when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-18T09:13:00.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-11T04:42:39.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T21:17:16.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1.0%
    Check dated 2025-02-10T10:18:03.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T09:27:22.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-01-27T03:52:12.000Z thumbnail image

Stay in the know with updates to Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.